Long-term maintenance with P2Y12 inhibitor monotherapy after discontinuing dual antiplatelet therapy (DAPT) in patients ...

Objective: To evaluate the relationship between early statin administration and hemorrhagic transformation (HT) in patients with acute ischemic stroke (AIS) patients following recanalization ...

The second is a hemorrhagic stroke, caused by a rupture in an artery in the brain, which in turn damages surrounding tissues. The third type of stroke is a transient ischemic attack—also known as a ...

In the pooled analysis, the relative risk of intracranial hemorrhage with apixaban versus aspirin ... the outcome of hemorrhagic stroke (relative risk, 0.72 [95% CI, 0.39–1.31]; P=0.28). In randomized ...

occlusion (LAAC-PO) for stroke prevention in patients with recurrent ... of cerebrovascular events (which we define to include transient ischemic attacks and other nonfatal ischemic or hemorrhagic ...

Treatment options depend on the type of stroke: ischemic or hemorrhagic. An ischemic stroke, by far the more common of the two, occurs when blood flow to the brain is blocked or reduced. The blockage ...

While glycoprotein (GP) IIb/IIIa inhibitors have been widely studied in ischemic stroke, cangrelor remains less explored. Objective To evaluate the safety and efficacy of cangrelor compared with GPIIb ...

The expanded acronym stands for: Ischemic Stroke: Caused by blood clots that occur in or travel to the brain Hemorrhagic Stroke: Results from burst blood vessels that cause bleeding in brain ...